APA (7th ed.) Citation

A, V., A, A., D, G., P, G., A, G., DM, R., . . . AK, S. (2025). Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) as a cause of new-onset refractory status epilepticus (NORSE): Case report and review of literature. Journal of neuroimmunology, 399, 578522. https://doi.org/10.1016/j.jneuroim.2025.578522

Chicago Style (17th ed.) Citation

A, Vaingankar, Agarwal A, Garg D, Gupta P, Garg A, Radhakrishnan DM, Pandit AK, and Srivastava AK. "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD) as a Cause of New-onset Refractory Status Epilepticus (NORSE): Case Report and Review of Literature." Journal of Neuroimmunology 399 (2025): 578522. https://doi.org/10.1016/j.jneuroim.2025.578522.

MLA (9th ed.) Citation

A, Vaingankar, et al. "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD) as a Cause of New-onset Refractory Status Epilepticus (NORSE): Case Report and Review of Literature." Journal of Neuroimmunology, vol. 399, 2025, p. 578522, https://doi.org/10.1016/j.jneuroim.2025.578522.